A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants with Obesity
Clinical Trials
Study
GLY-200-03
A 16-Week study to evaluate the efficacy, safety, and tolerability of GLY-200 in participants with obesity
Status:
Ongoing
Study
GLY-200-02
Phase 2 study of safety, tolerability, and pharmacodynamic effects of GLY-200 in type 2 diabetic patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients
Status:
Completed
Study
GLY-200-01
Phase 1 study of safety and tolerability of GLY-200 in healthy volunteers
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single & Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GLY-200 in Healthy Adult Subjects